MedNet Solutions Announces Key Enhancements to EMPOWER, Its Investigator Initiated-Sponsored Research Management Solution
MedNet Solutions is pleased to announce significant enhancements to EMPOWER™, the company’s investigator initiated ‐ sponsored research (IISR) management solution. The EMPOWER system is currently being utilized by pharmaceutical and medical device companies to automate and streamline investigator research submissions, management and reporting.
The EMPOWER enhancements, which are being rolled out in three separate releases during the third quarter of 2010, have been designed to: 1) increase the standard functionality available in each of the system’s core modules, 2) expand the inherent configurability of the system to meet each customer’s requirements, 3) add new standard reports and metrics that allow customers to continually improve their overall IISR management program.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
